#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperphagia Dent's disease Non-Hodgkin's lymphoma unspecified histology indolent Oropharyngeal squamous cell carcinoma Precursor T-lymphoblastic lymphoma/leukaemia recurrent Pleural mesothelioma malignant Rhabdomyosarcoma Bronchiolitis Neuroblastoma recurrent Corneal neovascularisation Cholestatic pruritus Cutaneous calcification Biliary neoplasm Alternating hemiplegia of childhood Synovitis More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Diagnostics Primary hyperoxaluria Osteosarcoma – Diagnostics Rhabdoid tumour – Basic Information Idiopathic inflammatory myopathy – Basic Information Alexander disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Crigler-Najjar syndrome – Diagnostics Retinoblastoma Haemophilia B without inhibitors – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Toripalimab Nms-03592088 Ataluren Bms-986315 Wt1 Lamp Mrna Dc Ferric Derisomaltose Pelareorep Magnesium Rilzabrutinib Gimeracil ALXN2420 Melphalan Tretinoin Caba-201 Collagenase Crgd-Zw800-1 His203-Crm197 Df6002 Apocynin Insulin Glargine More therapies…

    Learn about Your Condition

    Non-obstructive cardiomyopathy B-cell lymphoma refractory Thyroid cancer metastatic Immunodeficiency Antithrombin III deficiency Left ventricular dysfunction Bile acid synthesis disorder Tuberous sclerosis complex Renal cancer metastatic Alport's syndrome Hyperthyroidism Neuromuscular scoliosis Breast angiosarcoma Neuroblastoma recurrent Labour induction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Emmaues

Emmaues

Rvnynxmozw 1ug Dwgbbby 2ielb Bsajnac

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia France Hungary Italy +5
  • Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Iclepertin
    Austria Belgium Bulgaria Croatia Czechia Denmark +15
  • Testing BI 1569912 for Major Depressive Disorder in Patients Using Antidepressants

    Not recruiting

    2 1
    Investigated Diseases:
    • Major depression
    Belgium Bulgaria Czechia Germany

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!